No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
953 |
4. Check minimum number of eventsNone |
953 |
5. Include endpointsNone |
953 |
6. Filter based on genotype QC (FinnGen only) |
953 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Oral leukoplakia, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Oral leukoplakia and related diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5452 | 2705 | 2719 |
| Only index persons | 5235 | 2615 | 2620 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.08 | 0.08 |
| Only index persons | 0.10 | 0.10 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 57.42 | 59.83 | 55.09 |
| Only index persons | 57.24 | 59.67 | 54.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 953 | 492 | 461 |
| Unadjusted period prevalence (%) | 0.18 | 0.17 | 0.20 |
| Median age at first event (years) | 58.31 | 58.23 | 58.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 861
- Matched controls
- 8610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.20
ICD-10 Finland
Idiopathic leukoplakia
+∞
323.0
589
*
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
+∞
323.0
300
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
58.5
231.4
271
67
EKA10
NOMESCO Finland
Biopsy of cheek
34.9
154.0
202
75
K13.29
ICD-10 Finland
Indefinite leukoplakia
56.9
150.2
177
39
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
19.9
120.8
188
119
SAA03
NOMESCO Finland
Extended examination of mouth
4.6
96.7
536
2258
ECA20
NOMESCO Finland
Biopsy of gingiva
32.0
73.0
97
34
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
17.8
71.9
115
74
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
99.6
67.1
73
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
61.0
428
1925
L43.8
ICD-10 Finland
Other lichen planus
21.9
60.2
89
45
SXA10
NOMESCO Finland
Epithel biopsy of mouth
23.7
58.3
84
39
K13.78
ICD-10 Finland
Other change in the oral mucosa
14.8
56.7
97
73
SAA02
NOMESCO Finland
Basic examination of mouth
3.2
51.9
644
4136
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.2
49.7
359
1582
SBA00
NOMESCO Finland
Microbiological examinations
12.9
49.6
90
77
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
110.5
48.3
52
5
SAA01
NOMESCO Finland
Simple examination of mouth
3.1
44.4
679
4719
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
46.9
43.7
53
12
EHA10
NOMESCO Finland
Biopsy of palate
33.8
41.5
54
17
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.7
40.3
450
2511
A07AA02
ATC
nystatin; oral
5.2
39.1
130
284
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
16.0
39.0
64
43
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.9
38.6
114
216
WX110
NOMESCO Finland
Local anesthesy
2.7
37.4
654
4621
SAA04
NOMESCO Finland
Special inverstigation of mouth
5.8
37.2
112
217
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
64.3
32.3
37
6
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.5
31.3
97
194
L43.9
ICD-10 Finland
Lichen planus, unspecified
10.1
29.3
59
62
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
68.5
29.1
33
5
B37.08
ICD-10 Finland
Other candidal stomatitis
26.1
29.0
40
16
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.3
28.2
372
2134
K05.31
ICD-10 Finland
Periodontitis pronounced
3.3
27.8
155
535
K02.1
ICD-10 Finland
Caries of dentine
2.1
25.2
515
3533
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.1
22.7
507
3539
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
22.6
488
3360
D20
ICPC
Mouth/tongue/lip symptom/complaint
4.9
22.5
76
167
Z01.2
ICD-10 Finland
Dental examination
2.1
22.2
383
2399
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
2.3
21.5
251
1319
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
61.6
21.0
24
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.0
20.5
517
3717
TEA00
NOMESCO Finland
Biopsy of lip
12.0
20.4
37
32
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
49.3
20.2
24
5
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.8
20.0
137
536
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
19.7
391
2548
A01AB09
ATC
miconazole; local oral
3.1
19.7
119
428
EJ2S1
NOMESCO Finland
Photography of oral mucosa
107.5
19.6
21
*
N07BA03
ATC
varenicline; oral
4.0
19.2
79
211
WX290
NOMESCO Finland
Other blockade of nerve
2.0
18.9
383
2506
EBA00
NOMESCO Finland
Extraction of tooth
2.0
17.7
310
1906
K03.64
ICD-10 Finland
Dental calculus supragingival
2.1
17.3
253
1445
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.4
17.3
87
275
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
16.7
16.6
26
16
ZXC10
NOMESCO Finland
Use of laser
6.5
16.6
43
69
EKB00
NOMESCO Finland
Excision of lesion of cheek
17.1
16.1
25
15
WZA90
NOMESCO Finland
Other doctors statement
2.1
15.9
223
1247
SXC03
NOMESCO Finland
Other oral or dental procedure
10.7
15.8
30
29
D82
ICPC
Teeth/gum disease
1.9
15.8
301
1892
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
2.0
15.7
240
1385
GBB00
NOMESCO Finland
Tracheostomy
8.9
15.3
32
37
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
15.1
404
2837
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
12.7
14.9
26
21
SDA02
NOMESCO Finland
Parodonthologic therapy
1.9
14.9
293
1852
EJB40
NOMESCO Finland
Hemiglossectomy
57.7
14.8
17
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
16.8
14.8
23
14
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
14.7
422
3022
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.8
14.6
389
2717
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
+∞
14.6
14
*
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
36.7
14.5
18
5
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.1
14.2
191
1044
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
43.2
14.1
17
*
A01AC01
ATC
triamcinolone; local oral
6.5
13.3
34
54
K05.30
ICD-10 Finland
Periodontitis complex
2.3
13.3
133
635
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
13.2
394
2822
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
11.8
12.9
23
20
Z72.0
ICD-10 Finland
Tobacco use
4.7
12.8
43
95
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
70.9
12.6
14
*
K13.6
ICD-10 Finland
Irritative hyperplasia of oral mucosa
8.9
12.6
26
30
K02.0
ICD-10 Finland
Caries limited to enamel
2.3
12.4
116
536
EDB00
NOMESCO Finland
Partial excision of mandible
38.1
12.2
15
*
D07AD01
ATC
clobetasol; topical
2.1
12.0
144
748
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.8
11.8
242
1532
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
11.7
71
254
L43.3
ICD-10 Finland
Subacute (active) lichen planus
30.5
11.7
15
5
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
65.9
11.6
13
*
L43.0
ICD-10 Finland
Hypertrophic lichen planus
11.3
11.6
21
19
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.4
11.3
99
442
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
11.2
229
1443
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
11.1
103
475
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.8
11.0
218
1355
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.4
11.0
32
61
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
43.9
10.9
13
*
K03.66
ICD-10 Finland
Tooth plaque
2.7
10.8
74
286
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
60.8
10.6
12
*
J02AC01
ATC
fluconazole; systemic
1.7
10.5
313
2201
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.9
10.3
179
1064
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
23.7
10.3
14
6
XQ802
NOMESCO Finland
Epicutan test
3.8
10.1
42
115
SBB10
NOMESCO Finland
Teeth copy
2.9
10.1
62
225
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.7
10.0
220
1412
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
7.1
9.8
23
33
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
10.2
9.5
18
18
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
101.1
9.4
10
*
K13.24
ICD-10 Finland
Gum problems in smokers
101.1
9.4
10
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
17.8
9.4
14
8
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
30.4
9.4
12
*
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
+∞
9.4
9
*
K13.1
ICD-10 Finland
Cheek and lip biting
12.5
9.4
16
13
K12.10
ICD-10 Finland
Stomatitis NOS
10.8
9.3
17
16
A01AB04
ATC
amphotericin B; local oral
2.8
8.9
56
208
E0000UV
ATC
NA
1.6
8.8
311
2259
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.4
8.8
22
35
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.8
8.8
36
98
SPAT1301
SPAT
No procedures
1.6
8.8
261
1811
L84
ICD-10 Finland
Corns and callosities
3.4
8.7
40
120
K14.9
ICD-10 Finland
Disease of tongue, unspecified
14.2
8.7
14
10
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.7
8.6
204
1332
EMAK
NOMESCO Finland
NA
3.1
8.5
45
150
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.6
8.4
36
102
D07AC01
ATC
betamethasone; topical
1.6
8.4
289
2080
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.0
8.4
18
23
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.1
8.2
21
35
SXC05
NOMESCO Finland
Other oral or dental procedure
2.7
8.1
55
214
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
22.3
8.0
11
5
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.7
8.0
189
1229
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
8.0
550
4628
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
7.8
143
861
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
7.8
83
405
N05AH04
ATC
quetiapine; oral
1.8
7.8
134
788
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
7.6
110
608
E000001
ATC
NA
1.7
7.6
161
1012
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
6.2
7.6
19
31
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.9
7.6
108
598
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.4
7.5
34
102
SFA00
NOMESCO Finland
Small filling
1.9
7.5
105
574
L43.2
ICD-10 Finland
Lichenoid drug reaction
80.8
7.4
8
*
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
80.8
7.4
8
*
P17
ICPC
Tobacco abuse
5.4
7.4
21
40
KMAK
NOMESCO Finland
NA
1.5
7.4
406
3228
-1
NOMESCO Finland
NA
1.6
7.3
255
1831
ECA30
NOMESCO Finland
Excision of lesion of gingiva
5.5
7.3
20
37
WX199
NOMESCO Finland
Other local analgesia
3.5
7.2
31
90
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
4.4
7.1
24
56
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.6
7.0
30
86
N05BA01
ATC
diazepam; systemic, rectal
1.8
7.0
118
691
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
2.2
6.9
65
302
R03AC02
ATC
salbutamol; inhalant
1.5
6.9
412
3318
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.3
6.9
33
104
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
6.8
100
557
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.7
6.8
45
175
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.9
6.7
103
586
N06AX11
ATC
mirtazapine; oral
1.5
6.7
256
1872
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
22.7
6.7
9
*
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.5
6.6
18
33
J01FF01
ATC
clindamycin; systemic
1.5
6.6
231
1652
K04.09
ICD-10 Finland
Pulpit UNS
3.0
6.6
35
119
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.7
6.5
26
71
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.7
6.5
42
160
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.5
369
2931
K12.18
ICD-10 Finland
Other forms of stomatitis
6.2
6.5
16
26
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
6.4
134
838
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
6.4
129
796
K14.61
ICD-10 Finland
Glossodynia
7.5
6.4
14
19
VALMI
NOMESCO Finland
NA
1.6
6.4
180
1223
SPAT1310
SPAT
Counselling related to known health issue
1.5
6.3
253
1863
SBA10
NOMESCO Finland
Measurement of excretion of saliva
5.6
6.3
17
31
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.9
6.3
83
447
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
26.9
6.2
8
*
EKC00
NOMESCO Finland
Suture of cheek
26.9
6.2
8
*
8070/3-C06.9
ICD-O-3
Squamous cell carcinoma, NOS, of mouth, NOS
26.9
6.2
8
*
EAA10
NOMESCO Finland
Excision of lesion of lip
4.5
6.2
20
45
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
6.2
102
594
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.1
214
1525
L01
ICPC
Neck symptom/complaint
1.8
6.1
108
643
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.1
331
2595
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
6.0
181
1248
M79.1
ICD-10 Finland
Myalgia
1.8
6.0
97
560
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
87
91
10.42
75.62
2.2
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
197
1019
2.18
19.12
4.9
4.6
%
30.8
32.0
0.74
131
679
(3000494) Fungus identified in Specimen by Culture
195
1006
2.18
19.05
1.7
1.4
—
—
—
0
0
(3019225) pH of Specimen
162
777
2.31
18.88
3.5
4.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
438
3149
1.72
14.83
2.7
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
239
1484
1.81
13.21
1.7
1.7
nmol/l
1151.2
1219.8
0.52
175
1118
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
819
7176
2.00
12.61
5.7
4.7
mu/l
1.9
2.1
0.51
725
6531
(3013512) EKG study
346
2416
1.68
12.48
4.1
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
586
4720
1.63
11.62
4.9
5.1
mmol/l
6.9
6.7
1.22
556
4446
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
351
2506
1.63
11.36
2.3
2.1
u/l
257.0
224.0
0.19
325
2361
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
174
1027
1.85
11.16
7.6
7.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
158
913
1.88
10.82
1.8
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
473
3689
1.56
10.20
6.1
6.4
mmol/l
1.2
1.2
0.35
417
3350
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
432
3303
1.56
10.16
2.1
2.0
pmol/l
93.1
95.2
0.39
214
1696
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
71
310
2.39
10.13
1.8
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
504
4017
1.54
9.65
7.2
7.2
mmol/l
1.2
1.2
0.79
437
3418
(42870588) Differential panel, method unspecified - Blood
363
2694
1.56
9.59
6.2
5.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
66
286
2.40
9.58
1.6
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
724
6271
1.64
9.57
8.1
7.8
u/l
78.7
78.8
0.03
680
5887
(3024561) Albumin [Mass/volume] in Serum or Plasma
451
3521
1.53
9.42
4.7
4.9
g/l
35.4
35.4
0.09
418
3283
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
627
5261
1.56
9.38
3.9
3.2
u/l
51.9
53.9
0.22
569
4895
(3032080) INR in Blood by Coagulation assay
432
3349
1.53
9.28
6.4
9.1
inr
1.3
1.2
0.17
66
943
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
276
1948
1.59
8.95
2.5
2.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
687
5912
1.58
8.95
5.1
4.2
mm/h
13.1
12.5
0.53
616
5453
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
689
5951
1.57
8.66
4.7
3.9
pmol/l
15.0
14.9
0.26
599
5384
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
527
4319
1.49
8.33
5.8
6.5
umol/l
10.8
11.6
0.88
497
4110
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
463
3715
1.48
8.02
4.1
4.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
31
5.23
7.95
5.0
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
101
561
1.90
7.75
4.5
5.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
66
319
2.15
7.44
4.1
3.9
mmol/l
24.9
24.9
0.04
60
303
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
400
3160
1.46
7.28
3.6
3.7
ng/l
30.2
51.1
1.03
288
2273
(3044640) Blood type and Crossmatch panel - Blood
331
2529
1.47
7.12
2.6
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
333
2559
1.46
6.91
2.8
2.6
u/l
57.2
56.8
0.04
309
2365
(3019550) Sodium [Moles/volume] in Serum or Plasma
883
8276
1.91
6.47
20.4
17.0
mmol/l
139.2
139.7
5.63
863
8068
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
851
7890
1.73
6.47
17.8
14.7
mg/l
23.3
24.5
0.49
718
6285
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
403
3247
1.42
6.33
2.4
2.3
nmol/l
75.9
77.3
0.50
344
2892
(4010399)
101
601
1.76
6.21
1.5
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
883
8302
1.87
6.02
20.3
17.1
mmol/l
4.0
4.0
1.21
860
8082
(3017732) Neutrophils [#/volume] in Blood
89
518
1.79
5.90
2.5
3.1
e9/l
4.5
4.1
0.40
65
395
(3037467) Urinalysis macro (dipstick) panel - Urine
622
5441
1.41
5.88
4.7
4.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
214
2858
0.68
5.88
2.9
2.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
814
7502
1.58
5.85
6.7
6.0
mmol/mol
40.9
40.1
0.63
736
6941
(3018010) Neutrophils/100 leukocytes in Blood
452
3756
1.39
5.75
6.9
5.9
%
57.8
57.1
0.54
414
3515
(3022313) Gas panel - Capillary blood
70
382
1.90
5.70
4.0
3.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
123
793
1.63
5.63
2.1
2.2
g/l
0.2
0.2
0.21
115
745
(3013115) Eosinophils [#/volume] in Blood
487
4110
1.38
5.58
6.9
6.2
e9/l
0.2
0.2
0.92
433
3602
(3022217) INR in Platelet poor plasma by Coagulation assay
154
1052
1.55
5.52
25.8
23.3
inr
1.3
1.2
0.38
21
132
(3015377) Calcium [Moles/volume] in Serum or Plasma
343
2743
1.39
5.41
3.2
3.6
mmol/l
2.4
2.4
0.11
288
2399
(3013650) Neutrophils [#/volume] in Blood by Automated count
538
4629
1.37
5.39
9.1
9.4
e9/l
4.4
4.1
1.92
479
4060
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
139
935
1.57
5.33
2.7
1.9
%
1.7
1.5
2.37
116
811
(3019069) Monocytes/100 leukocytes in Blood
448
3750
1.37
5.31
7.7
6.3
%
8.6
8.8
0.53
410
3507
(3002030) Lymphocytes/100 leukocytes in Blood
454
3816
1.36
5.20
7.3
6.1
%
27.3
27.6
0.23
413
3553
(3008152) Bicarbonate [Moles/volume] in Arterial blood
88
533
1.72
5.10
6.9
8.4
mmol/l
24.6
24.7
0.05
82
500
(3006315) Basophils [#/volume] in Blood
471
3994
1.35
5.04
6.8
5.8
e9/l
0.0
0.0
2.61
419
3429
(3006504) Eosinophils/100 leukocytes in Blood
444
3735
1.35
4.99
7.2
6.0
%
2.9
2.9
0.12
409
3474
(3031040) Bacteria [#/volume] in Urine by Automated count
590
5185
1.36
4.98
4.9
4.4
e6/l
1248.7
2498.8
—
7
78
(40761511) CBC panel - Blood by Automated count
872
8239
1.69
4.87
18.0
13.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
252
1945
1.40
4.81
2.2
2.1
mg/l
2.9
3.1
0.59
209
1664
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
219
1659
1.42
4.64
1.3
1.2
u/ml
1.0
1.7
1.07
62
455
(3022096) Basophils/100 leukocytes in Blood
430
3630
1.34
4.60
7.3
6.1
%
0.7
0.7
1.77
393
3383
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
179
1312
1.45
4.53
1.9
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
465
3977
1.33
4.52
6.8
5.8
e9/l
0.6
0.6
1.65
413
3406
(3019198) Lymphocytes [#/volume] in Blood
472
4061
1.32
4.34
6.7
5.9
e9/l
1.9
2.0
0.30
427
3555
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
135
954
1.48
4.11
6.7
9.0
kpa
5.1
5.1
0.33
130
918
(3027801) Oxygen [Partial pressure] in Arterial blood
135
954
1.48
4.11
6.6
9.0
kpa
11.8
12.1
0.41
129
921
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
104
2.44
4.08
1.6
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
27
117
2.35
4.04
5.1
4.9
umol/l
386.9
371.9
0.23
21
102
(3003396) Base excess in Arterial blood by calculation
134
950
1.48
4.02
6.7
9.0
mmol/l
1.5
1.3
0.30
96
761
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
105
2.42
4.00
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
105
2.42
4.00
1.6
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
889
8499
1.69
4.00
12.8
10.8
u/l
26.4
26.9
0.41
855
8198
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
106
2.40
3.93
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
106
2.40
3.93
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
203
1561
1.38
3.89
4.2
3.9
ng/l
1235.2
401.0
0.39
156
1255
(3023520) Reticulocytes [#/volume] in Blood
100
674
1.54
3.81
2.1
2.8
e9/l
71.0
72.1
0.10
80
521
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
88
577
1.58
3.79
1.7
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
14
44
3.21
3.78
1.8
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
44
3.21
3.78
1.8
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
73
2.64
3.65
3.1
3.5
%
63.5
54.9
0.95
13
57
(3021960) Folate [Moles/volume] in Serum or Plasma
239
1909
1.34
3.56
1.7
1.5
nmol/l
18.7
20.6
1.44
202
1612
(3007461) Platelets [#/volume] in Blood
909
8772
1.79
3.55
26.9
21.6
e9/l
253.1
247.6
1.59
886
8538
(3048689) Calprotectin [Mass/mass] in Stool
124
889
1.45
3.52
2.0
2.2
ug/g
148.6
130.9
0.16
97
702
(3004789) Transferrin [Mass/volume] in Serum or Plasma
153
1140
1.41
3.52
2.5
2.4
g/l
2.3
2.3
0.37
145
1058
(40768443) Skin Pathology biopsy report
58
349
1.70
3.51
1.2
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
909
8775
1.78
3.50
26.8
21.5
pg
30.7
30.4
4.60
892
8640
(3024731) MCV [Entitic volume]
909
8776
1.77
3.49
26.8
21.5
fl
92.0
91.3
5.21
892
8641
(3026361) Erythrocytes [#/volume] in Blood
909
8776
1.77
3.49
26.9
21.6
e12/l
4.4
4.5
4.71
881
8519
(3010813) Leukocytes [#/volume] in Blood
909
8776
1.77
3.49
26.9
21.6
e9/l
7.0
6.7
4.01
884
8515
(3024522) Salmonella sp identified in Specimen by Organism specific culture
24
106
2.30
3.47
1.6
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
276
2258
1.31
3.47
4.2
4.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
177
1356
1.37
3.45
3.4
3.4
mmol/l
0.8
0.8
0.36
163
1271
(3042936) Bacteria identified in Isolate by Culture
160
1206
1.39
3.44
2.1
2.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
909
8779
1.77
3.44
27.0
21.7
g/l
135.1
136.1
1.14
894
8641
(3007164) IgA [Mass/volume] in Serum or Plasma
190
1476
1.36
3.39
1.3
1.5
g/l
2.6
2.6
0.06
112
896
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
828
7846
1.42
3.34
5.3
4.7
mmol/l
6.0
6.0
0.34
739
7135
(3009508) Creatinine [Moles/volume] in Urine
312
2611
1.29
3.28
3.7
3.2
mmol/l
7.0
7.5
1.27
253
2193
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
35
184
1.94
3.28
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
809
7650
1.38
3.17
4.7
4.1
mmol/l
1.5
1.3
0.97
719
6985
(4035726)
102
724
1.46
3.06
1.5
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
122
899
1.41
2.99
2.2
2.6
%
1.8
1.8
0.01
101
810
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
502
1.54
2.99
4.1
3.4
mmol/l
1.1
1.8
0.98
61
383
(3009343) pH of Capillary blood
78
527
1.52
2.98
4.1
3.4
—
7.4
—
0
76
(3012516) Albumin [Mass/volume] in Urine
297
2498
1.27
2.95
3.5
3.3
mg/l
258.9
208.9
0.08
176
1595
(3003458) Phosphate [Moles/volume] in Serum or Plasma
143
1086
1.37
2.94
5.7
5.8
mmol/l
1.0
1.0
0.42
132
1000
(40768797) Stomach Pathology biopsy report
148
1135
1.36
2.86
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
281
2358
1.27
2.83
3.3
3.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
78
534
1.50
2.81
4.1
3.4
kpa
5.2
5.2
0.19
68
505
(3008757) Leukocyte morphology finding [Identifier] in Blood
20
90
2.25
2.81
3.8
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
73
494
1.52
2.78
1.5
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
92
654
1.45
2.76
2.7
3.0
ng/l
205.7
196.7
0.09
84
602
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
62
407
1.56
2.71
2.5
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
99
718
1.42
2.67
2.2
2.5
ug/l
5.4
6.9
0.34
86
630
(3022948) Iron [Moles/volume] in Serum or Plasma
159
1248
1.33
2.64
2.4
2.4
umol/l
12.5
13.1
0.51
150
1152
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
140
1082
1.34
2.58
2.4
2.4
%
20.9
22.9
1.05
108
926
(1616796) Gas panel - Central venous blood
6
182
0.33
2.54
2.7
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
308
2641
1.25
2.54
4.0
4.0
mg/mmol
4.2
8.8
3.53
178
1674
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
439
1.52
2.52
8.0
12.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
75
2.29
2.52
6.6
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
233
1.70
2.49
1.5
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
21
3.83
2.46
1.5
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
36
211
1.73
2.46
1.9
1.7
e6/l
11665.3
15271.9
0.35
23
157
(4198724)
8
22
3.66
2.36
3.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
846
8136
1.35
2.30
5.8
5.1
mmol/l
2.7
2.8
2.74
767
7470
(40761536) Microorganisms panel - Urine sediment
42
651
0.63
2.30
3.5
3.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
23
3.50
2.27
7.4
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
71
503
1.44
2.21
2.1
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
613
6547
0.82
2.20
21.1
18.1
%
13.8
13.7
0.70
601
6401
(36660697) Celiac disease serology panel - Serum
80
580
1.41
2.20
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
42
2.64
2.19
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
826
7928
1.31
2.18
5.3
4.5
mmol/l
1.4
1.5
0.49
747
7274
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
213
1.67
2.12
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
830
7978
1.31
2.12
5.4
4.6
mmol/l
4.6
4.7
1.25
754
7369
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
109
1.95
2.11
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
474
1.44
2.11
1.2
1.2
iu/ml
318.8
145.5
1.51
25
193
(3004809) Band form neutrophils/100 leukocytes in Blood
24
131
1.85
2.09
2.7
3.6
%
1.6
1.3
0.18
19
112
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
124
1.88
2.08
1.4
1.7
g/l
0.5
0.9
1.39
15
96
(3001122) Ferritin [Mass/volume] in Serum or Plasma
359
3181
1.21
2.08
2.9
2.7
ug/l
137.6
141.9
0.11
317
2916
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
297
2587
1.22
2.04
3.9
3.4
u/l
50.9
32.9
0.46
280
2464
(3037522) Nuclear Ab [Titer] in Serum
134
1070
1.29
1.98
1.3
1.3
titre
649.6
510.8
0.27
25
236
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
116
909
1.31
1.97
5.1
4.3
u/l
224.4
254.8
1.92
107
859
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
39
2.58
1.92
1.8
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
39
2.58
1.92
1.8
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
312
3515
0.83
1.90
9.9
9.9
e9/l
0.0
0.0
0.05
256
2865
(40761535) Cells panel - Urine sediment
91
693
1.35
1.89
3.8
3.4
—
—
—
0
0
(4015189)
7
22
3.20
1.88
3.3
3.3
—
—
—
0
0
(4211845)
8
28
2.87
1.86
7.4
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
53
2.28
1.81
2.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
63
457
1.41
1.76
2.0
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
110
1.84
1.74
9.1
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
59
425
1.41
1.72
4.1
3.1
pmol/l
4.5
4.6
0.23
50
369
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
187
1.62
1.71
2.2
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
187
1.62
1.71
1.6
1.7
iu/l
5.5
4.7
—
6
56
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
243
1.54
1.70
1.6
1.6
iu/ml
2.5
0.1
—
8
41
(3026493) Urate [Moles/volume] in Serum or Plasma
250
2178
1.20
1.69
2.5
2.7
umol/l
1626.3
5523.9
1.75
207
1885
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
42
2.40
1.68
1.3
1.1
—
—
—
0
0
(4146454)
18
97
1.87
1.67
4.3
2.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
19
3.17
1.66
1.3
1.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
31
2.59
1.66
10.6
13.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
179
2099
0.82
1.64
3.6
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
49
680
0.71
1.60
3.1
4.1
mmol/l
1.2
1.2
0.22
41
599
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
32
2.51
1.60
1.3
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
6
20
3.01
1.58
1.5
1.3
mu/l
29.9
115.8
—
6
15
(3048879) Bone marrow aspiration report
7
26
2.70
1.58
2.0
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
11
50
2.21
1.57
1.9
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
256
2249
1.19
1.57
1.9
1.7
mmol/l
1.5
1.4
0.58
222
1890
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
137
1.70
1.56
5.6
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
202
1738
1.21
1.55
4.5
4.0
kg/l
1.0
1.0
0.02
29
229
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
15
3.35
1.52
2.8
1.9
umol/l
20.7
16.5
—
5
15
(3009542) Hematocrit [Volume Fraction] of Blood
746
7153
1.20
1.51
19.0
15.8
%
39.0
40.1
1.70
461
5026
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
871
1.27
1.51
3.3
4.3
ug/l
77.8
25.3
0.36
90
724
(3002256) Pathology report gross observation
125
1029
1.25
1.48
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
215
2455
0.84
1.47
3.3
3.3
e6/l
579.8
93.0
0.44
178
1912
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
437
0.65
1.47
1.3
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
38
2.38
1.46
2.0
2.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
102
1.78
1.45
1.6
1.6
%
64.8
61.3
0.17
13
72
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
16
3.14
1.44
1.6
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
1125
1.23
1.43
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
149
1.63
1.42
2.3
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
364
1.39
1.41
1.1
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
92
734
1.28
1.41
2.7
2.2
nmol/l
395.1
370.7
0.49
86
680
(3014765) Yersinia sp identified in Stool by Organism specific culture
34
230
1.50
1.40
1.2
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
190
2182
0.84
1.38
3.3
3.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
190
1.54
1.38
1.3
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
174
1.57
1.38
1.4
1.3
u/l
14.3
9.2
0.60
21
139
(3010375) cycloSPORINE [Mass/volume] in Blood
0
39
0.00
1.34
0.0
30.8
—
128.6
—
0
32
(42529406) Shigella sp [Presence] in Stool by Culture
34
233
1.48
1.33
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
66
509
1.32
1.32
1.8
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
185
2118
0.84
1.30
4.5
4.0
estimate
0.0
0.0
0.69
39
697
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
91
1.77
1.29
1.1
1.1
u/ml
0.2
6.8
—
5
46
(3018095) Leukocytes [#/volume] in Urine
254
2832
0.86
1.28
3.6
3.8
e6/l
28.3
120.4
2.72
191
2050
(3027456) Digoxin [Moles/volume] in Serum or Plasma
26
170
1.54
1.27
2.5
3.1
nmol/l
0.8
0.9
0.54
18
135
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
35
2.30
1.27
1.3
2.1
ug/l
79.1
56.5
—
8
35
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
783
7574
1.19
1.26
14.4
13.6
ml/min/173m2
81.5
79.4
2.15
660
6266
(3021901) Oxygen saturation in Capillary blood
8
157
0.51
1.25
2.4
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
85
1.78
1.23
1.1
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
199
2254
0.85
1.23
3.3
3.2
e6/l
0.4
0.5
0.25
163
1714
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
19
2.64
1.21
1.8
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
37
2.17
1.21
1.0
3.2
u/ml
736.9
1529.1
—
8
37
(3022145) Colonoscopy Study observation
112
935
1.22
1.19
1.3
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
175
1524
1.18
1.19
3.0
3.1
mmol/l
2.4
2.5
0.78
153
1343
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
231
1.44
1.18
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
30
206
1.47
1.18
1.7
3.3
umol/l
32.4
34.5
0.16
25
173
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
149
1.56
1.18
1.1
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
185
0.54
1.16
1.1
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
65
1.86
1.13
3.3
1.6
%
9.0
10.6
0.93
12
65
(3016879) Cocaine [Presence] in Urine
25
167
1.51
1.13
5.6
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
31
2.27
1.10
1.1
3.0
—
74227.2
—
0
6
(3022621) pH of Urine by Test strip
63
497
1.29
1.10
3.2
2.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
21
2.39
1.09
4.8
8.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
261
1.39
1.09
1.8
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
52
667
0.77
1.08
1.8
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
147
1687
0.85
1.07
2.7
3.0
ug/l
0.6
0.7
1.67
86
1081
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
193
1712
1.16
1.05
1.8
1.7
pmol/l
455.4
37288567.6
1.91
150
1416
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
149
0.53
1.04
1.6
3.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
78
637
1.24
1.04
4.1
3.7
ng/l
74.4
85.2
0.95
61
563
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
238
1.40
1.03
1.4
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
22
2.28
1.03
1.2
1.1
pmol/l
142.8
330.3
—
5
12
(4034850)
17
263
0.64
1.03
21.9
10.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
14
83
1.70
1.01
1.6
1.3
e6/l
9161.1
127898.8
—
7
61
(3044941) Cell count panel - Synovial fluid
21
139
1.52
1.00
1.6
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
37
274
1.36
1.00
3.4
3.5
mg/l
44.5
75.3
0.68
31
220
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
37
274
1.36
1.00
3.4
3.5
mg/l
30.1
42.5
0.54
30
222
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
110
0.45
1.00
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
270
2461
1.14
1.00
2.5
3.0
ng/l
1110.3
1215.8
0.28
229
2094
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
81
668
1.23
0.99
2.2
2.7
ml/min/173m2
72.1
64.7
0.87
38
271
(44813793)
9
49
1.84
0.98
1.1
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
160
0.56
0.98
4.1
3.3
e9/l
3.9
4.3
—
9
160
(3051611) Lipemic interference index of Serum or Plasma
14
84
1.68
0.98
3.1
3.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
639
6637
0.89
0.98
24.8
19.1
g/l
333.1
332.5
1.02
633
6589
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
30
0.00
0.97
0.0
1.1
—
77.4
—
0
5
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
50
1.81
0.96
1.4
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
157
1.48
0.96
1.4
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
113
1313
0.84
0.96
3.1
3.0
e6/l
2.2
2.0
0.19
71
726
(3052851) Hemolysis interference index of Serum or Plasma
33
242
1.38
0.96
3.7
3.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
32
0.00
0.95
0.0
4.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
24
166
1.46
0.95
1.1
1.2
—
8.3
—
0
12
(3000492) Spirometry study
95
801
1.21
0.95
1.7
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
143
0.56
0.94
1.5
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
107
914
1.19
0.93
2.4
2.8
umol/l
9.0
9.1
0.01
90
809
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
176
1.43
0.91
1.4
1.4
miu/ml
394.2
198.0
—
6
83
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
386
1.28
0.90
3.9
3.6
mmol/l
23.8
24.4
0.57
44
340
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
6
29
2.08
0.89
3.0
1.8
umol/l
60.2
87.2
—
6
18
(3005719) IgG [Mass/volume] in Serum or Plasma
75
622
1.22
0.89
2.9
2.9
g/l
11.5
10.6
0.65
67
577
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
104
0.48
0.89
1.2
2.4
pg
29.8
32.6
—
5
104
(3044290) Cell count panel - Cerebral spinal fluid
9
156
0.57
0.88
2.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
197
1774
1.14
0.88
1.6
1.7
mg/l
1.1
1.2
0.06
145
1378
(3000764) Benzodiazepines [Presence] in Urine
25
178
1.42
0.87
5.7
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
44
344
1.29
0.86
1.1
1.1
—
146.2
—
0
9
(3006653) Thiamine [Moles/volume] in Blood
8
44
1.82
0.86
1.1
1.4
nmol/l
170.8
155.0
—
8
44
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
170
1.42
0.86
4.0
3.5
mg/l
19.7
25.8
0.36
11
102
(3003327) Ova and parasites identified in Stool by Light microscopy
31
230
1.36
0.85
1.2
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
167
0.59
0.85
4.1
3.7
%
55.9
57.4
—
10
167
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
239
1.35
0.85
1.3
1.4
ug/g
247.1
278.3
0.45
17
139
(40760892) CBC W Ordered Manual Differential panel - Blood
156
1747
0.87
0.84
5.7
4.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
57
1.76
0.84
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
57
1.76
0.84
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
57
1.76
0.84
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
46
1.75
0.82
4.1
3.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
46
1.75
0.82
2.5
1.2
ug/l
7.3
5.9
—
8
39
(3027008) Opiates [Presence] in Urine
25
180
1.40
0.82
5.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
180
1.40
0.82
5.8
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
223
2034
1.13
0.82
7.2
6.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
81
1.61
0.81
2.4
2.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
164
1.41
0.80
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
164
1.41
0.80
1.5
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
58
1.73
0.80
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
58
1.73
0.80
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
58
1.73
0.80
1.0
1.1
—
—
—
0
0
(4094501)
32
242
1.33
0.79
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
106
1.52
0.79
1.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
2.3
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
74
1.63
0.78
1.4
1.3
g/l
5.4
7.7
—
7
53
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
74
1.63
0.78
1.4
1.3
g/l
0.5
0.4
—
7
51
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
2.3
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
30
227
1.33
0.75
1.1
1.2
—
13.8
—
0
12
(3000093) Morphology [Interpretation] in Blood Narrative
11
67
1.65
0.75
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
42
334
1.27
0.74
2.2
2.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
361
1.26
0.74
1.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
184
0.65
0.74
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
51
417
1.24
0.72
1.3
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
12
76
1.59
0.72
1.9
1.3
—
38.2
—
0
5
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
21
151
1.40
0.71
2.9
1.2
u/l
39.5
29.9
0.26
16
129
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
265
1.29
0.71
1.6
1.6
—
—
—
0
0
(4062490)
12
77
1.57
0.68
1.3
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
25
187
1.35
0.68
1.8
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
102
1.48
0.67
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
303
1.26
0.67
1.3
2.0
g/l
3.4
3.1
0.76
24
247
(3027944) Amphetamines [Presence] in Urine
24
179
1.35
0.67
3.5
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
369
3892
0.92
0.66
3.8
3.7
estimate
0.0
0.0
0.00
39
719
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
495
1.20
0.66
1.2
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
126
1406
0.88
0.66
2.9
2.8
e6/l
0.8
1.1
0.63
84
813
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
155
0.64
0.66
2.6
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
111
1.45
0.66
1.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
107
946
1.15
0.65
2.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
4.0
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
29
1.73
0.64
1.2
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
4.0
2.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
190
1.32
0.63
1.3
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
31
391
0.79
0.63
3.6
3.6
%
53.4
47.6
0.75
31
384
(3019832) Treponema pallidum Ab [Presence] in Serum
45
370
1.23
0.62
2.1
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
96
1.47
0.61
1.5
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
30
1.67
0.61
4.0
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
111
991
1.14
0.60
1.9
1.7
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
114
1.41
0.59
1.1
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.1
—
17.0
—
0
5
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
74
848
0.86
0.58
3.5
3.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
132
1.37
0.57
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
167
1.32
0.57
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
73
1.51
0.56
1.2
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
3.5
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
3.5
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
3.5
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
3.5
1.9
—
—
—
0
0
(44790047)
14
99
1.42
0.54
1.1
1.7
—
—
—
0
0
(44790049)
14
99
1.42
0.54
1.1
1.7
—
—
—
0
0
(44806118)
14
99
1.42
0.54
1.1
1.7
—
—
—
0
0
(44790048)
14
99
1.42
0.54
1.1
1.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
9
61
1.48
0.53
1.1
1.0
—
0.9
—
0
18
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
142
1298
1.11
0.53
1.3
1.2
u/ml
16.5
11.4
0.30
44
506
(1761482) Bacteria [#/volume] in Urine by Culture
16
215
0.74
0.53
2.8
4.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
72
632
1.15
0.51
2.8
2.3
nmol/l
12.0
13.3
0.79
62
562
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
41
1.47
0.50
3.2
1.5
umol/l
6.1
4.9
—
6
24
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
216
1.26
0.50
1.7
2.4
ug/min
75.1
87.5
0.14
15
124
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
10
67
1.50
0.50
1.6
1.4
nmol/l
0.2
0.3
—
5
49
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
280
1.22
0.49
1.2
2.2
g/l
0.6
1.1
0.40
25
252
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
326
1.20
0.49
1.3
2.0
g/l
4.0
3.8
0.46
23
243
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
326
1.20
0.49
1.3
2.0
g/l
7.5
7.4
0.09
25
255
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
326
1.20
0.49
1.3
2.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
41
346
1.19
0.47
2.1
2.1
ug/l
0.7
2.1
0.97
35
313
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
129
1.32
0.46
1.2
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
103
1.36
0.45
1.4
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
24
192
1.26
0.45
1.8
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
85
763
1.13
0.45
4.2
3.4
mmol/l
1.1
2.1
1.17
73
607
(3021601) Nitrite [Presence] in Urine by Test strip
375
3901
0.94
0.44
5.2
5.0
estimate
0.0
0.0
0.00
46
723
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
219
2321
0.93
0.44
4.1
4.1
%
20.4
21.0
0.23
85
1060
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
543
0.86
0.44
1.4
1.4
—
—
—
0
0
(3020891) Body temperature
40
340
1.18
0.43
6.4
4.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
303
1.20
0.43
1.3
2.0
g/l
11.3
10.7
0.29
24
268
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
92
0.65
0.42
4.7
4.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
289
3028
0.93
0.42
3.9
3.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
87
1.38
0.42
2.3
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
57
1.41
0.42
3.5
3.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
22
176
1.26
0.42
2.0
2.2
g/l
124.7
129.2
0.33
14
131
(3000330) Specific gravity of Urine by Test strip
34
401
0.84
0.41
2.3
3.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
34
287
1.19
0.40
5.4
2.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.3
—
7.9
—
0
10
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
105
0.66
0.39
1.9
2.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
35
1.43
0.39
1.0
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
472
4585
1.06
0.37
2.8
2.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
198
1.22
0.36
1.8
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
81
1.36
0.36
2.4
1.9
—
—
—
0
0
(4024509)
9
71
1.27
0.36
1.4
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
42
1.43
0.35
2.7
2.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
208
1.21
0.35
4.2
3.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
80
0.62
0.35
1.6
2.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
90
827
1.10
0.34
1.6
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
943
1.09
0.34
2.1
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
45
1.34
0.33
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
45
1.34
0.33
1.5
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
20
164
1.22
0.32
3.3
3.6
u/ml
57.8
1735.6
0.61
20
158
(21494755) Public health laboratory ask at order entry panel
58
642
0.90
0.31
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
850
1.09
0.31
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
202
1.19
0.31
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
186
0.80
0.31
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
194
1847
1.06
0.31
3.9
3.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
54
1.30
0.30
1.9
1.3
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
7
54
1.30
0.30
2.7
2.2
ug/l
3.6
2.0
—
7
46
(3045142) Bone marrow Pathology biopsy report
12
93
1.29
0.30
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
383
3941
0.95
0.29
3.9
3.7
estimate
0.0
0.0
0.80
39
697
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
298
2879
1.05
0.28
4.6
4.7
ug/l
1.7
2.3
2.10
258
2590
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
103
1.27
0.28
1.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
65
595
1.10
0.28
2.8
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
63
1.27
0.27
2.0
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
145
1374
1.07
0.27
1.3
1.3
iu/ml
64.8
32.9
0.95
40
423
(3023419) Bacteria identified in Sputum by Culture
9
121
0.74
0.27
2.2
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
321
0.87
0.27
1.8
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
30
262
1.15
0.27
1.3
2.0
g/l
37.6
37.7
0.03
22
231
(1002224) Polysomnography panel
30
341
0.88
0.26
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
72
1.25
0.25
1.3
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
9
75
1.20
0.25
2.3
2.2
—
1.1
—
0
5
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
96
1.25
0.24
1.2
1.3
nmol/l
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
6
82
0.73
0.24
1.2
1.3
mmol/l
8.3
6.8
—
6
77
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
143
1.19
0.23
2.0
1.9
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
93
0.75
0.22
1.1
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
251
2431
1.04
0.22
4.5
4.1
ph
7.4
7.4
0.50
29
467
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
210
1.15
0.22
1.4
1.3
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.1
—
32.2
—
0
7
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
43
1.16
0.21
2.2
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
1.7
—
0
13
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
6.6
—
0
13
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
5.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.7
—
51.9
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
117
1.20
0.20
1.2
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
117
1.20
0.20
1.1
1.1
—
17.3
—
0
7
(3021440) Promyelocytes/100 leukocytes in Blood
61
655
0.93
0.20
4.0
4.6
%
0.2
0.1
0.17
26
194
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
6.7
—
0
7
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
155
0.84
0.20
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
213
2062
1.04
0.19
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
511
1.08
0.19
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
184
1.14
0.19
3.8
2.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
122
0.82
0.19
1.1
1.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
53
1.13
0.18
1.3
1.2
u/l
16.0
11.6
—
6
46
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
58
1.21
0.18
1.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
153
1588
0.96
0.18
2.6
2.8
mosm/kgh2o
551.3
556.8
0.10
132
1361
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
100
1.20
0.18
1.0
1.4
pmol/l
289.3
313.0
—
7
83
(3025159) Blasts/100 leukocytes in Blood
58
620
0.93
0.18
4.0
4.7
%
0.1
0.6
0.45
21
166
(3002179) Metamyelocytes/100 leukocytes in Blood
59
630
0.93
0.18
3.9
4.4
%
0.9
0.5
0.74
20
159
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
70
1.14
0.16
1.3
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
72
1.11
0.16
2.6
2.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
111
1.17
0.16
1.2
1.3
nmol/l
0.6
0.7
0.86
13
101
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
79
1.14
0.15
1.6
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
80
1.13
0.15
1.8
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
213
0.89
0.15
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
171
0.88
0.14
1.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
83
1.09
0.14
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
87
0.80
0.14
3.6
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
131
1.15
0.14
1.7
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
198
1.11
0.14
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
81
775
1.05
0.13
2.2
2.5
u/l
74.8
33.8
0.63
68
661
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
151
1.13
0.13
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
9
107
0.84
0.13
1.8
1.4
g/l
32.9
32.0
—
9
96
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
241
0.91
0.12
1.7
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
73
699
1.05
0.12
3.3
2.7
g/l
67.4
66.8
0.34
61
642
(3044889) 12 lead EKG panel
585
5797
1.02
0.12
4.0
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
165
1692
0.97
0.11
2.6
2.6
e6/l
4.8
5.2
0.27
148
1497
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
201
1.10
0.11
1.6
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
126
0.87
0.11
1.5
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
105
1.14
0.11
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
66
687
0.96
0.10
9.3
9.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
45
1.11
0.10
2.4
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
784
1.04
0.09
1.6
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
133
0.90
0.07
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
73
0.82
0.07
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
75
0.80
0.07
1.5
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
74
1.08
0.07
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
75
1.07
0.07
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
88
1.02
0.07
1.4
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
296
1.05
0.06
2.3
3.5
g/l
0.2
0.2
0.12
11
126
(3002523) Influenza virus A Ag [Presence] in Specimen
11
120
0.92
0.05
1.4
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
209
1.05
0.04
1.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
68
695
0.98
0.04
4.1
4.5
%
0.8
0.9
0.40
27
214
(3003740) Influenza virus B Ag [Presence] in Specimen
11
119
0.92
0.04
1.4
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
200
1.05
0.03
1.5
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
129
0.93
0.03
1.6
2.5
u/ml
14428.1
127.8
0.47
12
124
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
99
977
1.01
0.03
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
340
1.03
0.03
1.8
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
241
1.04
0.02
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
269
0.97
0.02
2.5
2.7
u/ml
0.3
0.4
0.24
15
151
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
137
0.95
0.01
1.5
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
173
1.04
0.01
1.8
2.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
136
0.96
0.00
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
142
0.99
0.00
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
252
0.99
0.00
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
19
185
1.03
0.00
1.2
2.2
nmol/l
0.8
0.9
0.41
14
154
(3042631) Mycobacterium sp identified in Specimen
11
115
0.96
0.00
2.4
2.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
81
0.99
0.00
1.3
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
69
1.01
0.00
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.7
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
16.6
—
0
5
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
82
0.98
0.00
1.3
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
59
0.85
0.00
1.6
2.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
49
1.02
0.00
1.2
1.9
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
130
1.00
0.00
1.1
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
88
0.91
0.00
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
78
0.90
0.00
3.0
1.4
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.9
—
2.1
—
0
7
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
76.6
—
0
7
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.9
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
2.5
—
0
8
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
392.6
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
79
1.01
0.00
2.3
2.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_ORAL_LEUCOPLACIA_INCLAVO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_ORAL_LEUCOPLACIA_INCLAVO | 1.138 [0.99, 1.31] | 0.067 |
| Birth year | 0.989 [0.98, 1.0] | 0.017 |
During the follow-up period (1.1.1998 — 31.12.2019), 415 out of 2412 females with K11_ORAL_LEUCOPLACIA_INCLAVO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_ORAL_LEUCOPLACIA_INCLAVO | 1.208 [1.05, 1.39] | 0.008 |
| Birth year | 0.987 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 419 out of 2342 males with K11_ORAL_LEUCOPLACIA_INCLAVO died.
Mortality risk
Mortality risk for people of age
years, who have K11_ORAL_LEUCOPLACIA_INCLAVO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.085% | 0.16% |
| 5 | 0.554% | 1.325% |
| 10 | 1.446% | 3.321% |
| 15 | 2.758% | 6.967% |
| 20 | 4.837% | 11.545% |
Relationships between endpoints
↥Index endpoint: K11_ORAL_LEUCOPLACIA_INCLAVO – Oral leukoplakia, including avohilmo
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data